Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Bruker Corp Preliminary Expectation For Revenue For Q4 2022 To Be Up Low Single Digits % YoY, A Result Of Organic Growth Of Mid-To-High Single Digits % YoY; Initial Guidance For 2023 For Organic Revenue Growth Up Mid-To-High Single Digit % YoY

On January 9, 2023 during its scheduled presentation at the 41st Annual J.P. Morgan Healthcare Conference, Bruker Corporation (the “Company”) stated that its current preliminary expectation for revenue for

BRKR